Journal of Diabetes Investigation
Издатель: Wiley · ISSN 20401116 · 71 статей
- Class effect beyond glucose: Implications of the LEGEND‐T2DM findings for cardiovascular outcomes
- Commentary on: Genetic predictors of GLP1 receptor agonist weight loss and side effects (Nature volume 653, pages 770–775 (2026))
- Circadian metabolic dysfunction in MASLD: Physiological insights and future directions
-
Changes in liver steatosis and liver stiffness following Empagliflozin treatment in patients with MASLD and type 2 diabetes: A single‐arm pre–post study
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is common in subjects with type 2 diabetes mellitus (T2DM), being linked to a higher risk for the development of liver‐related and cardiovascular...
-
Cost‐effectiveness analysis comparing advanced hybrid closed‐loop automated insulin delivery with multiple daily insulin injections and continuous glucose monitoring in adults with type 1 diabetes in Japan
ABSTRACT Aim The use of automated insulin delivery systems, including the MiniMed™ 780G advanced hybrid closed‐loop system, has been shown to improve glycemic management in people with type 1 diabetes (T1D). The aim was to assess the...
-
Diagnostic model based on machine learning with multi‐feature analysis for diabetic peripheral neuropathy in type 2 diabetes: A single‐center retrospective study
ABSTRACT Objective Diabetic peripheral neuropathy (DPN) is a common and serious complication of diabetes, which imposes a significant economic burden on both society and individuals. Therefore, early identification and diagnosis are...
-
The clock‐output gene DBP regulates muscle insulin sensitivity and its fluctuations
ABSTRACT Objective Circadian rhythm disruption is associated with metabolic disorders, yet the role of clock genes in glucose metabolism remains unclear. D‐box binding protein (DBP) is a clock output gene that activates the D‐box, and...
-
The low fasting serum C‐peptide level was associated with reduced sural nerve action potential amplitudes: A cross‐sectional study of Japanese type 2 diabetes
ABSTRACT Aims/Introduction The association between the fasting serum C‐peptide levels and diabetic polyneuropathy (DPN) in patients with type 2 diabetes remains controversial. Furthermore, the association with the electrophysiological...
-
Real‐world effectiveness and safety of enavogliflozin in patients with type 2 diabetes: A 24‐week prospective multicenter observational study in Korea
ABSTRACT Aims/Introduction To evaluate the real‐world effectiveness and safety of enavogliflozin as a single‐pill formulation (Enavo group; enavogliflozin 0.3 mg) or fixed‐dose combination with metformin (EnavoMet group; enavogliflozin...
- Comment on “Effects of age, sex, and renal function on bowel movement‐improving effects of Bifidobacterium bifidum G9‐1 on constipation in patients with type 2 diabetes mellitus and chronic kidney disease: A prespecified subgroup analysis of the BIRDIE study”
-
USP25 promotes ferroptosis in diabetic retinopathy by deubiquitinating p53 and suppressing the GPX4/SLC7A11 axis
ABSTRACT Objective To explore the expression of the deubiquitinase (DUB) USP25 in diabetic retinopathy (DR) and its mechanistic role in regulating ferroptosis. Methods Bioinformatics was used to screen for DR‐related DUB candidate...
-
Parasympathetic dysfunction assessed by deep‐breathing CVR‐R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study
ABSTRACT Aims/Introduction Although glucagon‐like peptide‐1 receptor agonists are widely used for type 2 diabetes, gastrointestinal intolerance frequently leads to early discontinuation. Predictors of oral semaglutide discontinuation...
-
History of gastrointestinal symptoms with other glucose‐lowering agents is associated with gastrointestinal adverse events after imeglimin initiation: A retrospective real‐world study
ABSTRACT Aims/Introduction Imeglimin is an oral antidiabetic agent with a novel mechanism of action. Gastrointestinal (GI) adverse events (AEs) have been reported during imeglimin therapy. However, the factors associated with the...
-
Association between the cholesterol‐high‐density lipoprotein‐glucose index and the incidence of new‐onset diabetes in patients with chronic gastrointestinal diseases: A prospective cohort study
ABSTRACT Aims This study aimed to investigate the association between the cholesterol‐high‐density lipoprotein‐glucose (CHG) index and the incidence of diabetes in patients with chronic gastrointestinal diseases (CGID). Methods This...
-
Association between thyroid feedback quantile‐based index and the risk of in‐hospital amputation in patients with diabetic foot ulcer
ABSTRACT Aims To investigate the relationship between the thyroid feedback quantile‐based index (TFQI) and the risk of amputation during hospitalization in patients with diabetic foot ulcers (DFU). Methods This single‐center...
- Methodological considerations in interpreting serum galectin‐3 as a predictor of incident type 2 diabetes
-
Adrenal hormones in the maintenance of glucose homeostasis during prolonged fasting in male glucagon‐deficient mice
ABSTRACT Aims/Introduction Glucagon is a key regulator of fasting glucose homeostasis, but the contribution of adrenal hormones during prolonged fasting remains unclear. We investigated the complementary roles of glucagon and adrenal...
-
Association between low‐carbohydrate diet scores and macrovascular events or all‐cause mortality in adults with type 1 diabetes in Japan
ABSTRACT Aims/Introduction The effects of lifestyle factors on macrovascular events or all‐cause mortality remain unclear in type 1 diabetes. We examined the associations of diet, physical activity, and sleep with these outcomes among...
- Hepatic steatosis and postprandial hyperglucagonemia in early type 2 diabetes: Revisiting the liver–α‐cell axis
-
The cholesterol, high‐density lipoprotein, and glucose index and its derivatives related to obesity and inflammation as novel metabolic markers for predicting new‐onset cardiovascular‐liver‐metabolic multimorbidity: A prospective cohort study
ABSTRACT Background Cardiovascular‐liver‐metabolic multimorbidity (CLMM), defined as the co‐occurrence of at least two of cardiovascular disease, type 2 diabetes, and metabolic dysfunction‐associated steatotic liver disease, is an...
-
Diabetes attenuates weight reduction‐mediated liver fibrosis regression in persons with morbid obesity
ABSTRACT Aims Weight loss by laparoscopic sleeve gastrectomy (LSG) compared to medical weight loss (low‐calorie diet: LCD) ameliorates diabetes and metabolic dysfunction‐associated steatotic liver disease (MASLD). We aimed to evaluate...
-
A study of changes in insulin requirements related to the menstrual cycle in Japanese women with type 1 diabetes using the advanced hybrid closed‐loop system
ABSTRACT Aims/Introduction In type 1 diabetes (T1D), insulin requirements and glycemic control may vary across the menstrual cycle. We examined phase‐related differences in insulin requirements, glycemic metrics, and recorded...
-
LGR6 couples maresin 1 signaling to glycolytic flux and protein lactylation for the rescue of diabetic cardiomyopathy
ABSTRACT Background Diabetic cardiomyopathy (DbCM) is driven by metabolic inflexibility and impaired mitochondrial clearance. While the pro‐resolving lipid mediator Maresin 1 (MaR1) shows therapeutic promise, its capacity to correct the...
-
Fasting proinsulin as a predictor of future glucose tolerance deterioration in Japanese adults
ABSTRACT Aims/Introduction Proinsulin is associated with β‐cell stress and has been linked to subsequent deterioration in glucose metabolism in Western populations, but its predictive value in Asian populations remains unclear. We...
-
Renal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis
ABSTRACT Kidney disease is a major microvascular complication of diabetes, affecting approximately 40% of individuals with diabetes, and is a leading cause of end‐stage renal disease. Besides the functional consequences of...
-
Exploring the associations of overweight and obesity with pregnancy outcomes in type 1 and type 2 diabetes: An Australian retrospective cohort study
ABSTRACT Objective To explore the associations of maternal overweight/obesity and pre‐pregnancy body mass index (BMI) on glycemia and pregnancy outcomes in women with pregestational type 1 diabetes mellitus (T1DM) or type 2 diabetes...
- Erythritol and metabolic dysfunction‐associated steatotic liver disease: A sweet friend, bitter foe, or reliable fellow traveler?
-
Comparison of three gestational weight gain guidelines for adverse pregnancy outcomes in Chinese women with gestational diabetes: A cohort study
ABSTRACT Background This study aimed to assess the associations between post‐diagnostic gestational weight gain (GWG) and adverse pregnancy outcomes among women with gestational diabetes mellitus (GDM) and to systematically compare the...
-
Metabolic health, independent of body mass index, is associated with mortality risk in type 1 diabetes
ABSTRACT Aims/Introduction Although a low body mass index (BMI) is traditionally associated with high mortality in type 1 diabetes (T1D), the increasing prevalence of obesity and its association with mortality warrant further research....
-
Circulating miR‐342‐3p as a biomarker for diagnosing gestational diabetes mellitus and predicting adverse perinatal outcomes: A retrospective cohort study
ABSTRACT Aims This study evaluated the clinical utility of circulating miR‐342‐3p for diagnosing gestational diabetes mellitus (GDM) and predicting adverse perinatal outcomes (APOs). Methods A retrospective cohort of 261 GDM women (the...